Using the information from AppleResources_Lesson5.docx (Balance Sheet, Income Statement and Statement of Cash Flows), compute the following Ratios for 2012:

1.Current Ratio = Total Current Assets/Total Current Liabilities

2.Debt to Equity Ratio = Total Liabilities/Total Shareholders’ Equity

3.Inventory Turnover Ratio = Cost of Sales/Average Inventory

4.Return on Assets Ratio = Net Income/Average Total Assets

5.Gross Margin Ratio = Gross Profit/Net Sales

6.Profit Margin Ratio = Net Income/Net Sales

7.Return on Equity Ratio = Net Income/Average Shareholders’ Equity

8.Working Capital = Total Current Assets – Total Current Liabilities

Apple 10-K; Sep 29, 12 (Selected
statements)
CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions,
except number of shares which are reflected in thousands and per share amounts)

Years
ended

September 29, 2012

September 24, 2011

September 25, 2010

Net sales

$

156,508

$

108,249

$

65,225

Cost of sales

87,846

64,431

39,541

Gross margin

68,662

43,818

25,684

Operating expenses:

Research and development

3,381

2,429

1,782

Selling, general and administrative

10,040

7,599

5,517

Total operating expenses

13,421

10,028

7,299

Operating income

55,241

33,790

18,385

Other income/(expense), net

522

415

155

Income before provision for income taxes

55,763

34,205

18,540

Provision for income taxes

14,030

8,283

4,527

Net income

$

41,733

$

25,922

$

14,013

Earnings per share:

Basic

$

44.64

$

28.05

$

15.41

Diluted

$

44.15

$

27.68

$

15.15

Shares used in computing earnings per share:

Basic

934,818

924,258

909,461

Diluted

945,355

936,645

924,712

Cash dividends declared per common share

$

2.65

$

0.00

$

0.00

CONSOLIDATED BALANCE SHEETS

(In millions,
except number of shares which are reflected in thousands)

September 29, 2012

September 24, 2011

ASSETS:

Current assets:

Cash and cash equivalents

$

10,746

$

9,815

Short-term marketable securities

18,383

16,137

Accounts receivable, less allowances of $98 and $53,
respectively

10,930

5,369

Inventories

791

776

Deferred tax assets

2,583

2,014

Vendor non-trade receivables

7,762

6,348

Other current assets

6,458

4,529

Total current assets

57,653

44,988

Long-term marketable securities

92,122

55,618

Property, plant and equipment, net

15,452

7,777

Goodwill

1,135

896

Acquired intangible assets, net

4,224

3,536

Other assets

5,478

3,556

Total assets

$

176,064

$

116,371

LIABILITIES
AND SHAREHOLDERS’ EQUITY:

Current liabilities:

Accounts payable

$

21,175

$

14,632

Accrued expenses

11,414

9,247

Deferred revenue

5,953

4,091

Total current liabilities

38,542

27,970

Deferred revenue – non-current

2,648

1,686

Other non-current liabilities

16,664

10,100

Total liabilities

57,854

39,756

Commitments and contingencies

CONSOLIDATED
BALANCE SHEETS (cont)

(In millions,
except number of shares which are reflected in thousands)

Shareholders’
equity:

Common stock, no par value; 1,800,000 shares authorized;
939,208 and 929,277 shares issued and outstanding, respectively

16,422

13,331

Retained earnings

101,289

62,841

Accumulated other comprehensive income

499

443

Total shareholders’ equity

118,210

76,615

Total liabilities and shareholders’ equity

$

176,064

$

116,371

CONSOLIDATED
STATEMENTS OF CASH FLOWS

(In millions)

Years
ended

September 29,

2012

September 24,

2011

September 25,

2010

Cash and cash equivalents, beginning of the year

$

9,815

$

11,261

$

5,263

Operating activities:

Net income

41,733

25,922

14,013

Adjustments to reconcile net income to cash generated by
operating activities:

Depreciation and amortization

3,277

1,814

1,027

Share-based compensation expense

1,740

1,168

879

Deferred income tax expense

4,405

2,868

1,440

Changes in operating assets and liabilities:

Accounts receivable, net

(5,551

)

143

(2,142

)

Inventories

(15

)

275

(596

)

Vendor non-trade receivables

(1,414

)

(1,934

)

(2,718

)

Other current and non-current assets

(3,162

)

(1,391

)

(1,610

)

Accounts payable

4,467

2,515

6,307

Deferred revenue

2,824

1,654

1,217

Other current and non-current liabilities

2,552

4,495

778

Cash generated by operating activities

50,856

37,529

18,595

Investing activities:

Purchases of marketable securities

(151,232

)

(102,317

)

(57,793

)

Proceeds from maturities of marketable securities

13,035

20,437

24,930

Proceeds from sales of marketable securities

99,770

49,416

21,788

Payments made in connection with business acquisitions,
net of cash acquired

(350

)

(244

)

(638

)

Payments for acquisition of property, plant and equipment

(8,295

)

(4,260

)

(2,005

)

Payments for acquisition of intangible assets

(1,107

)

(3,192

)

(116

)

Other

(48

)

(259

)

(20

)

Cash used in investing activities

(48,227

)

(40,419

)

(13,854

)

Financing activities:

Proceeds from issuance of common stock

665

831

912

Excess tax benefits from equity awards

1,351

1,133

751

Dividends and dividend equivalent rights paid

(2,488

)

0

0

Taxes paid related to net share settlement of equity
awards

(1,226

)

(520

)

(406

)

Cash (used in)/generated by financing activities

(1,698

)

1,444

1,257

Increase/(decrease) in cash and cash equivalents

931

(1,446

)

5,998

Cash and cash equivalents, end of the year

$

10,746

$

9,815

$

11,261

Supplemental cash flow disclosure:

Cash paid for income taxes, net

$

7,682

$

3,338

$

2,697